Throat Cancer
10
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
DESTINY-PANTUMOUR04
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
Somesthesia in Cancer Patients: Variability and Influence on Eating Experience
Quest to Analyze One Thousand Humans Meditating
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Fecal Screening Assay for Taiwanese Population